Water, Cocamidopropyl Betain, Decyl Glucoside, Sodium Methyl Cocoyl Taurate, Disodium
Lauroamphodiacetate, PEG-150 Distearate, Glycerin, Polyquaternium-10, Coconut oil, Panthenol,
Xanthan Gum, Oatmeal Extract, Allantoin, Vitamin E, Lonicera Japonica Extract , Bitter Melon Extract ,
Phenoxyethanol , Disodium EDTA, Ethylhexyl Glycerin, Fragrance.

Gel

Use a daily shower to help clean dirt and grime
skin and hair, cleans scalp scales in children, helps skin and hair
clean, fragrant.
– Moisturizes, maintains natural moisture for skin, improves mood
Condition: Heat rash, red rash, diaper rash, baby eczema, milk pimples in children

Devil’s claw extract, Methyl salicylate, menthol, capsaicin

Gel

– Reduce muscle aches and pains after hard working, playing sports.
– Treatment of pain: headache caused by weather, pain caused by poor posture, sedentary, or overactive.
– Sprains, hematomas, bruises, cases of swelling due to strong impact.

Ondansetron (as Ondansetron hydrochloride dihydrate) 4mg/5ml

Liquid solution

The management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention of post-operative nausea and vomiting in adults.

Chemotherapy and radiotherapy induced nausea and vomiting.

Adults:

The emetogenic potential of cancer treatment varies according to the doses and combinations of chemotherapy and radiotherapy regimens used. The selection of dose regimen should be determined by the severity of the emetogenic challenge.

Emetogenic chemotherapy and radiotherapy: Nausazy can be given either by rectal, oral (tablets or syrup), intravenous or intramuscular administration.

For oral administration: 8 mg taken 1 to 2 hours before chemotherapy or radiation treatment, followed by 8 mg every 12 hours for a maximum of 5 days to protect against delayed or prolonged emesis.

For highly emetogenic chemotherapy: a single dose of up to 24 mg Nausazy taken with 12 mg oral dexamethasone sodium phosphate, 1 to 2 hours before chemotherapy, may be used.

To protect against delayed or prolonged emesis after the first 24 hours, oral or rectal treatment with Nausazy may be continued for up to 5 days after a course of treatment.

The recommended dose for oral administration is 8 mg to be taken twice daily.

Paediatric Population:

CINV in children aged ≥ 6 months and adolescents:

The dose for CINV can be calculated based on body surface area (BSA) or weight – see below. In paediatric clinical studies, ondansetron was given by IV infusion diluted in 25 to 50 mL of saline or other compatible infusion fluid and infused over not less than 15 minutes.

Weight-based dosing results in higher total daily doses compared to BSA-based dosing.

There are no data from controlled clinical trials on the use of Nausazy in the prevention of delayed or prolonged CINV. There are no data from controlled clinical trials on the use of Nausazy for radiotherapy-induced nausea and vomiting in children.

Dosing by BSA:

Nausazy should be administered immediately before chemotherapy as a single intravenous dose of 5 mg/m². The single intravenous dose must not exceed 8 mg.

Oral dosing can commence 12 hours later and may be continued for up to 5 days (Table 1). The total dose over 24 hours (given as divided doses) must not exceed adult dose of 32 mg.

Table 1: BSA-based dosing for Chemotherapy – Children aged ≥6 months and adolescents

a The intravenous dose must not exceed 8 mg.

b The total dose over 24 hours (given as divided doses) must not exceed adult dose of 32 mg

Dosing by bodyweight:

Weight-based dosing results in higher total daily doses compared to BSA-based dosing.

Nausazy should be administered immediately before chemotherapy as a single intravenous dose of 0.15 mg/kg. The intravenous dose must not exceed 8 mg.

Two further intravenous doses may be given in 4-hourly intervals.

Oral dosing can commence 12 hours later and may be continued for up to 5 days (Table 2). The total dose over 24 hours (given as divided doses) must not exceed adult dose of 32 mg.

Table 2: Weight-based dosing for Chemotherapy – Children aged ≥6 months and adolescents

a The intravenous dose must not exceed 8 mg.

b The total dose over 24 hours (given as divided doses) must not exceed adult dose of 32 mg.

Elderly:

No alteration of oral dose or frequency of administration is required.

Post operative nausea and vomiting (PONV).

Adults:

For the prevention of PONV: Nausazy can be administered orally or by intravenous or intramuscular injection.

For oral administration: 16 mg one hour prior to anaesthesia.

For the treatment of established PONV: Intravenous or intramuscular administration is recommended.

Paediatric population:

PONV in children aged ≥ 1 month and adolescents

Oral formulation:

No studies have been conducted on the use of orally administered ondansetron in the prevention or treatment of post-operative nausea and vomiting; slow IV injection (not less than 30 seconds) is recommended for this purpose.

Injection:

For prevention of PONV in paediatric patients having surgery performed under general anaesthesia, a single dose of ondansetron may be administered by slow intravenous injection (not less than 30 seconds) at a dose of 0.1 mg/kg up to a maximum of 4 mg either prior to, at or after induction of anaesthesia.

For the treatment of PONV after surgery in paediatric patients having surgery performed under general anaesthesia, a single dose of Nausazy may be administered by slow intravenous injection (not less than 30 seconds) at a dose of 0.1 mg/kg up to a maximum of 4 mg.

There are no data on the use of Nausazy in the treatment of PONV in children below 2 years of age.

Elderly:

There is limited experience in the use of Nausazy in the prevention and treatment of PONV in the elderly, however Nausazy is well tolerated in patients over 65 years receiving chemotherapy.

For both indications:

Patients with Renal impairment:

No alteration of daily dosage or frequency of dosing, or route of administration are required.

Patients with Hepatic impairment:

Clearance of Nausazy is significantly reduced and serum half life significantly prolonged in subjects with moderate or severe impairment of hepatic function. In such patients a total daily dose of 8 mg should not be exceeded.

Patients with poor Sparteine/Debrisoquine Metabolism:

The elimination half-life of ondansetron is not altered in subjects classified as poor metabolisers of sparteine and debrisoquine. Consequently in such patients repeat dosing will give drug exposure levels no different from those of the general population. No alteration of daily dosage or frequency of dosing is required.

Sorbitol 50%; Sodium citrate 7.2%

Laxative enema

Helps relieve constipation caused by rectum and anus.
Prepare rectal colonoscopy

Dosage: use 1 tube 1 day, 5-20 minutes before going to the toilet

1. DIABETEGEN is a derma-cosmetic of a new generation that aids in the regeneration of skin that is problematic, weak or prone to injuries.

2. DIABETEGEN owes its effectiveness to its main component, which is the highest of quality Colostrum – the rarest as well as the strongest natural substance occurring in nature that stimulates the body to self-regenerate and to improve its natural immunity. Aiding substances include Allantoin, Panthenol, Colloidal Silver and Vitamin E.

3. DIABETEGEN thoroughly cleanses the base layers of the skin and regulates the bacteriostatic environment. All of this is possible thanks to such natural substances as Lactoferrin, Lactoperoxidase, or Ionic Colloidal Silver.

4. DIABETEGEN has been created without the use of any artificial preservatives, fragrances or derivatives of petroleum whatsoever. Its very simple composition reduces the risk of topical allergic reactions to a minimum. The preparation process guarantees 100% of growth factor bioactivity preservation – priceless for skin regeneration.

5. DIABETEGEN has been dermatologically tested. It is recommended by the PDA (Polish Diabetes Association).

Bacillus clausii 2 x 10^9 CFU/5ml

Oral suspension

Treatment and prevention of intestinal bacterial flora disorders and malabsorption of endogenous vitamin
Adjuvant therapy restores the intestinal flora balance upset during treatment with antibiotics or chemotherapeutic products
Digestive disorders and chronic or acute diarrhea in children, caused by intestinal bacterial flora and vitamin malabsorption

Adults: 2-3 plastic ampoules a day
Childrens: 1-2 plastic ampoules a day or as directed by doctor

Prednisolon acetate 1mg
Lidocain 60mg
Allantoin 20mg
Tocopherol acetate 50mg

Suppository

Making wounds, crevices cracked.
Improve blood circulation, blockage.
Preventing the formation of hemorrhoids, anal fissures.
Loss of burning sensation, itching, bleeding, discomfort and cramping
Suppress local pain, itching, burning pain when using the toilet.
Inhibits the nerves causing painful sensations, reduces the swollen tissue.
Anti-inflammatory, bleeding, swelling, itching

Dosage: 1 tablet / day for no more than 10 consecutive days.
How to use:
– Clean the anal area with warm water or diluted saline. Then dry gently.
– Use the hand to push the bullet in the direction of the bullet into the anus 2 to 3 cm so that the hand does not reach the bullet.
– Wash hands after handling.
Note: Use before going to bed

Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus paracasei: total 3*10^10 cfu/suppository

Suppository

– Maintains the balance of vaginal microflora thanks to its high adhesion to the vaginal mucosa, creating a protective barrier against pathogens thereby preventing vaginal infections.
– Use in cases of dyspareunia, itching, burning, dryness or odor in the vagina. Case of vaginal discharge with bad odor, gray or grayish-white or yellow-green or “cottage cheese-like”, frothy discharge.
– Use in case of vaginal microflora imbalance due to long-term use of antibiotics.
– Supply probiotics on a frequent basis for premeopausal, meonopausal, postmenopausal women, diabetic women and immunocompromised women.
– Prevent from risk of preterm birth.

Orafti P95 2000 mg/10 ml
Plum Juice Powder 100 mg/10 ml
Oat P.E 50 mg/10 ml
Apple Pectin 50 mg/10 ml

Oral solution

Natural fiber supplement, laxative, relieves constipation

– Adults, pregnancy and woman after labor: 1 ampoule daily
– Children from 2 years old: 1/2 to 1 ampoule daily
– Children under 2 years old: 1/2 ampoule daily, consult the doctor before use

Each 5 ml contains:
Rotundine sulfate: 40mg
Saffron extract:   20 mg
Dried leaf Erythrina variegata extract:   30 mg
Embryo Nelumbinis extract:   25 mg

Oral solution

People with insomnia, sleeplessness, difficulty sleeping, especially in Elderly

Aldults: 1-2 ampoule

Children from 2 years old: 1 ampoule

Children below 2 years old: Asking doctor

Taking SIX.AM before going to sleep 30 minutes

Shake well before using

Dequalinium chloride, β-glycyrrhetinic acid (Enoxolon), Hydrocortisone acetate, Tyrothricin, Lidocaine hydrochloride

Solution

Support the treatment of oral – pharyngeal diseases: tonsillitis, pharyngitis, laryngitis, stomatitis, mouth ulcers, apricotosis, glossitis.

Each 10ml ampoule contains:
Iron (as Iron (III) hydroxide polymaltose) 50mg

Oral solution

Prevention and supported treatment of iron deficiency inanemia.

Use for Pregnant, Breastfeeding, Undernourished people. Children of iron deficiency anemia, growth retardation

Dosage and duration of treatment depend on the level of iron deficiency.
Daily dosage can be divided into small doses or one dose. Should drink during meal or right after meal.
Adult and children over 12 years: 1 ampoule each time, 2 times per day.
Children under 12 years: 1 ampoule each time, 1-2 times per day.
Or follow the advice, guidance of doctors for each specific case.